These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7051489)
1. Difference in posttransplant recovery of immune reactivity between allogeneic and autologous bone marrow transplantation. Shiobara S; Harada M; Mori T; Kodo H; Ishino C; Matsue K; Odaka K; Kondo K; Hattori K Transplant Proc; 1982 Jun; 14(2):429-33. PubMed ID: 7051489 [No Abstract] [Full Text] [Related]
2. Immune recovery following bone marrow transplantation. Schwenke H; Leiblein S; Pönisch W; Kubel M; Helbig W Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):509-18. PubMed ID: 2480300 [TBL] [Abstract][Full Text] [Related]
3. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis. Elfenbein GJ; Anderson PN; Humphrey RL; Mullins GM; Sensenbrenner LL; Wands JR; Santos GW Transplant Proc; 1976 Dec; 8(4):641-6. PubMed ID: 136774 [No Abstract] [Full Text] [Related]
4. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation]. Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068 [TBL] [Abstract][Full Text] [Related]
5. Immunodeficiency following allogeneic bone marrow transplantation. Gale RP; Opelz G; Mickey MR; Graze PR; Saxon A Transplant Proc; 1978 Mar; 10(1):223-7. PubMed ID: 147534 [No Abstract] [Full Text] [Related]
6. Immunologic reactivity in marrow graft recipients. Storb R; Ochs HD; Weiden PL; Thomas ED Transplant Proc; 1976 Dec; 8(4):637-9. PubMed ID: 793117 [No Abstract] [Full Text] [Related]
7. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. Pauksen K; Linde A; Ljungman P; Bolme P; Lönnerholm G; Oberg G; Sjölin J Bone Marrow Transplant; 1995 Dec; 16(6):807-13. PubMed ID: 8750274 [TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Roberts MM; To LB; Gillis D; Mundy J; Rawling C; Ng K; Juttner CA Bone Marrow Transplant; 1993 Nov; 12(5):469-75. PubMed ID: 7905331 [TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797 [TBL] [Abstract][Full Text] [Related]
10. Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation. Auletta JJ; Devecchio JL; Ferrara JL; Heinzel FP Biol Blood Marrow Transplant; 2004 Dec; 10(12):834-47. PubMed ID: 15570252 [TBL] [Abstract][Full Text] [Related]
11. Primary immunodeficiency diseases. Report prepared for the WHO by a scientific group on immunodeficiency. Clin Immunol Immunopathol; 1983 Sep; 28(3):450-75. PubMed ID: 6349887 [No Abstract] [Full Text] [Related]
12. Cell-mediated and humoral types of immunologic immunity in idiopathic pancytopenia. Traczyk Z; Orczyńska E; Cieśluk S Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):1-7. PubMed ID: 312631 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies. Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S Clin Transpl; 1996; ():281-90. PubMed ID: 9286578 [TBL] [Abstract][Full Text] [Related]
14. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients. Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739 [TBL] [Abstract][Full Text] [Related]
15. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma]. Sansoni P; Rossetti A; Valente G; Butturini U Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048 [No Abstract] [Full Text] [Related]
16. T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation. Ueda M; Harada M; Shiobara S; Nakao S; Kondo K; Odaka K; Matsue K; Mori T; Hattori K Transplantation; 1984 Jun; 37(6):552-6. PubMed ID: 6427996 [TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity in the gecko, Tarentola annularis. Badir N; Afifi A; El Ridi R Folia Biol (Praha); 1981; 27(1):28-36. PubMed ID: 7009229 [TBL] [Abstract][Full Text] [Related]
18. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation. Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067 [TBL] [Abstract][Full Text] [Related]
19. Cimetidine does not influence immunological parameters in man. ten Berge RJ; de Pauw BE; Smeulders J; Wagener DJ Clin Immunol Immunopathol; 1981 Oct; 21(1):33-8. PubMed ID: 6456100 [No Abstract] [Full Text] [Related]
20. [Post-vaccination immunity after allogenic and autologous bone marrow transplantation]. Skovránková J Cas Lek Cesk; 1999 May; 138(10):298-300. PubMed ID: 10422338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]